An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)

NCT00002090 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Mycobacterium Avium-Intracellulare Infection
HIV Infections

Interventions

DRUG: Azithromycin

Sponsor

Pfizer